MedPath
FDA Approval

HYALURONIDASE

HF Acquisition Co LLC, DBA HealthFirst (DUNS: 045657305)

June 4, 2021

HUMAN PRESCRIPTION DRUG LABEL

Registrants (1)

HF Acquisition Co LLC, DBA HealthFirst

045657305

Manufacturing Establishments (1)

HF Acquisition Co LLC, DBA HealthFirst

HF Acquisition Co LLC, DBA HealthFirst

HF Acquisition Co LLC, DBA HealthFirst

045657305

Products (1)

HYALURONIDASE

51662-1555

BLA021859

BLA (C73585)

SUBCUTANEOUS

June 4, 2021

SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74Class: IACTQuantity: 1.4 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8.5 mg in 1 mL
ALBUMIN HUMANInactive
Code: ZIF514RVZRClass: IACTQuantity: 1 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.2 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
METHIONINEInactive
Code: AE28F7PNPLClass: IACTQuantity: 1.5 mg in 1 mL
Code: 743QUY4VD8Class: ACTIBQuantity: 150 [USP'U] in 1 mL
© Copyright 2025. All Rights Reserved by MedPath